Back

VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

iwNHL 2015 | iwNHL 2015 roundtable: Immune checkpoint blockade for non-Hodgkin lymphoma

Anas Younes, John Gribben, Nathan Fowler and Stephen Ansell • 3 Oct 2015

At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, John Gribben, MD, DSc, FRCPath, FRCP FMedSci, of Barts and The London School of Medicine and Dentistry, London, UK, chairs a discussion with Anas Younes, MD, of Memorial Sloan Kettering Cancer Center, New York, NY, Stephen M. Ansell, MD, PhD, of Mayo Clinic, Rochester, MN, and Nathan H. Fowler, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, on emerging immune targets, such as the interaction between programmed death ligand-1 (PD-L1) and programmed cell death-1 (PD-1), that are demonstrating clinical responses with the use of immune checkpoint inhibitors in patients with non-Hodgkin lymphoma.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter